Journal of Immunology Research / 2018 / Article / Fig 3

Research Article

A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer

Figure 3

NIRF and ultrasound bimodal images of IR783-NBs-Affibody in vitro. (a) A LSCM image of IR783-NBs-Affibody. (b) The contrast-enhanced ultrasound images of IR783-NBs-Affibody, SonoVue microbubbles, and PBS in vitro, respectively.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.